Safety and Effectiveness of HIV-1 DNA Plasmid Vaccine and HIV-1 Recombinant Adenoviral Vector Vaccine in HIV-Uninfected, Circumcised Men and Male-to-Female (MTF) Transgender Persons Who Have Sex With Men

Clinical trial NCT00865566 · TERMINATED

Trial details

NCT number

NCT00865566

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Status

TERMINATED

Phase

Phase 2

Study type

INTERVENTIONAL

Start date

2009-05-01

Primary completion

2017-10-06

Enrollment

2504

View on ClinicalTrials.gov